MedTech News
.................... by Andrew Celentano
Scientists test new ways to regrow joints damaged by arthritis
The Advanced Research Projects Agency for Health (ARPA-H) said several experimental treatments could help regrow cartilage and bone in folks with osteoarthritis.
A new add-on for combat PTSD treatment: MRI-guided TMS significantly reduces symptoms in clinical trial
An advanced version of a procedure using magnetic fields to stimulate brain nerve cells in treating depression was significantly effective for 85% of active military and veterans suffering from combat post-traumatic stress disorder enrolled in a recent study, when added to psychotherapy.
Smart MRI molecules developed to detect and treat cancer
Researchers at NYU Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care.
Scientists reveal a new way cancer cells survive DNA damage
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized.
Virus from seafood is linked to a persistent eye disease in humans
A virus that typically infects marine animals, such as shrimp and fish, has jumped to humans and is causing chronic eye disease in some people, according to a study published in the journal Nature Microbiology.
InVera Medical Receives FDA Clearance for InVera Infusion Device – a Novel Non-Thermal Catheter for Enhanced Infusion of Sclerosant for Chronic Venous Disease
Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium in London on Tuesday, April 21st, 2026.
Stereotaxis wins FDA clearance for Synchrony cath lab tech
Stereotaxis (NYSE:STXS) announced today that it received FDA 510(k) clearance for its Synchrony system.
VDyne secures FDA nod to start pivotal trial for tricuspid valve
With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.